Florida Senate - 2019 CS for CS for SB 182
By the Committees on Innovation, Industry, and Technology; and
Health Policy; and Senator Brandes
1 A bill to be entitled
2 An act relating to the safe medical use of marijuana;
3 amending s. 381.986, F.S.; redefining the term
4 “marijuana delivery device” to eliminate the
5 requirement that such devices must be purchased from a
6 medical marijuana treatment center; redefining the
7 term “medical use” to include the possession, use, or
8 administration of marijuana in a form for smoking;
9 restricting smoking of marijuana in enclosed indoor
10 workplaces; conforming a provision to changes made by
11 the act; requiring a patient’s informed consent form
12 to include the risks specifically associated with
13 smoking marijuana; requiring a certifying physician to
14 make a determination in concurrence with a second
15 physician who meets specified requirements before
16 certifying a patient under 18 years of age who is not
17 diagnosed with a terminal condition to smoke marijuana
18 for medical use; requiring that marijuana in a form
19 for smoking meet certain packaging and labeling
20 requirements; deleting a provision prohibiting a
21 medical marijuana treatment center from dispensing or
22 selling specified products; allowing marijuana
23 delivery devices to be purchased from a vendor other
24 than a medical marijuana treatment center; providing
25 applicability; repealing proviso language in s. 3, ch.
26 2018-9, Laws of Florida, relating to salaries and
27 benefits positions and other personnel services of the
28 Department of Health; providing an effective date.
31 Be It Enacted by the Legislature of the State of Florida:
33 Section 1. Paragraphs (g) and (j) of subsection (1),
34 paragraph (a) of subsection (4), paragraph (e) of subsection
35 (8), subsection (14), and subsection (15) of section 381.986,
36 Florida Statutes, are amended to read:
37 381.986 Medical use of marijuana.—
38 (1) DEFINITIONS.—As used in this section, the term:
39 (g) “Marijuana delivery device” means an object used,
40 intended for use, or designed for use in preparing, storing,
41 ingesting, inhaling, or otherwise introducing marijuana into the
42 human body, and which is dispensed from a medical marijuana
43 treatment center for medical use by a qualified patient, except
44 that delivery devices intended for the medical use of marijuana
45 by smoking need not be dispensed from a medical marijuana
46 treatment center in order to qualify as marijuana delivery
48 (j) “Medical use” means the acquisition, possession, use,
49 delivery, transfer, or administration of marijuana authorized by
50 a physician certification. The term does not include:
51 1. Possession, use, or administration of marijuana that was
52 not purchased or acquired from a medical marijuana treatment
54 2. Possession, use, or administration of marijuana in
55 form for smoking, in the form of commercially produced food
56 items other than edibles , or of marijuana seeds or flower,
57 except for flower in a sealed, tamper-proof receptacle for
59 3. Use or administration of any form or amount of marijuana
60 in a manner that is inconsistent with the qualified physician’s
61 directions or physician certification.
62 4. Transfer of marijuana to a person other than the
63 qualified patient for whom it was authorized or the qualified
64 patient’s caregiver on behalf of the qualified patient.
65 5. The smoking of marijuana in an enclosed indoor workplace
66 as defined in s. 386.203(5).
67 6. 5. Use or administration of marijuana in the following
69 a. On any form of public transportation, except for low-THC
71 b. In any public place, except for low-THC cannabis.
72 c. In a qualified patient’s place of employment, except
73 when permitted by his or her employer.
74 d. In a state correctional institution, as defined in s.
75 944.02, or a correctional institution, as defined in s. 944.241.
76 e. On the grounds of a preschool, primary school, or
77 secondary school, except as provided in s. 1006.062.
78 f. In a school bus, a vehicle, an aircraft, or a motorboat,
79 except for low-THC cannabis.
81 For the purposes of this subparagraph, the exceptions for low
82 THC cannabis do not include the smoking of low-THC cannabis.
83 (4) PHYSICIAN CERTIFICATION.—
84 (a) A qualified physician may issue a physician
85 certification only if the qualified physician:
86 1. Conducted a physical examination while physically
87 present in the same room as the patient and a full assessment of
88 the medical history of the patient.
89 2. Diagnosed the patient with at least one qualifying
90 medical condition.
91 3. Determined that the medical use of marijuana would
92 likely outweigh the potential health risks for the patient, and
93 such determination must be documented in the patient’s medical
94 record. If a patient is younger than 18 years of age, a second
95 physician must concur with this determination, and such
96 concurrence must be documented in the patient’s medical record.
97 4. Determined whether the patient is pregnant and
98 documented such determination in the patient’s medical record. A
99 physician may not issue a physician certification, except for
100 low-THC cannabis, to a patient who is pregnant.
101 5. Reviewed the patient’s controlled drug prescription
102 history in the prescription drug monitoring program database
103 established pursuant to s. 893.055.
104 6. Reviews the medical marijuana use registry and confirmed
105 that the patient does not have an active physician certification
106 from another qualified physician.
107 7. Registers as the issuer of the physician certification
108 for the named qualified patient on the medical marijuana use
109 registry in an electronic manner determined by the department,
111 a. Enters into the registry the contents of the physician
112 certification, including the patient’s qualifying condition and
113 the dosage not to exceed the daily dose amount determined by the
114 department, the amount and forms of marijuana authorized for the
115 patient, and any types of marijuana delivery devices needed by
116 the patient for the medical use of marijuana.
117 b. Updates the registry within 7 days after any change is
118 made to the original physician certification to reflect such
120 c. Deactivates the registration of the qualified patient
121 and the patient’s caregiver when the physician no longer
122 recommends the medical use of marijuana for the patient.
123 8. Obtains the voluntary and informed written consent of
124 the patient for medical use of marijuana each time the qualified
125 physician issues a physician certification for the patient,
126 which shall be maintained in the patient’s medical record. The
127 patient, or the patient’s parent or legal guardian if the
128 patient is a minor, must sign the informed consent acknowledging
129 that the qualified physician has sufficiently explained its
130 content. The qualified physician must use a standardized
131 informed consent form adopted in rule by the Board of Medicine
132 and the Board of Osteopathic Medicine, which must include, at a
133 minimum, information related to:
134 a. The Federal Government’s classification of marijuana as
135 a Schedule I controlled substance.
136 b. The approval and oversight status of marijuana by the
137 Food and Drug Administration.
138 c. The current state of research on the efficacy of
139 marijuana to treat the qualifying conditions set forth in this
141 d. The potential for addiction.
142 e. The potential effect that marijuana may have on a
143 patient’s coordination, motor skills, and cognition, including a
144 warning against operating heavy machinery, operating a motor
145 vehicle, or engaging in activities that require a person to be
146 alert or respond quickly.
147 f. The potential side effects of marijuana use.
148 g. The risks, benefits, and drug interactions of marijuana.
149 h. The risks specifically associated with smoking
151 i. h. That the patient’s de-identified health information
152 contained in the physician certification and medical marijuana
153 use registry may be used for research purposes.
155 For a patient not diagnosed with a terminal condition, if the
156 patient is younger than 18 years of age and the certifying
157 physician intends to certify the patient’s medical use of
158 marijuana by way of smoking, the certifying physician must
159 determine that smoking is the most effective means of
160 administering medical marijuana for the patient and a second
161 physician must concur with that determination. The second
162 physician must be a pediatrician. Such determination and
163 concurrence must be documented in the patient’s medical record.
164 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—
165 (e) A licensed medical marijuana treatment center shall
166 cultivate, process, transport, and dispense marijuana for
167 medical use. A licensed medical marijuana treatment center may
168 not contract for services directly related to the cultivation,
169 processing, and dispensing of marijuana or marijuana delivery
170 devices, except that a medical marijuana treatment center
171 licensed pursuant to subparagraph (a)1. may contract with a
172 single entity for the cultivation, processing, transporting, and
173 dispensing of marijuana and marijuana delivery devices. A
174 licensed medical marijuana treatment center must, at all times,
175 maintain compliance with the criteria demonstrated and
176 representations made in the initial application and the criteria
177 established in this subsection. Upon request, the department may
178 grant a medical marijuana treatment center a variance from the
179 representations made in the initial application. Consideration
180 of such a request shall be based upon the individual facts and
181 circumstances surrounding the request. A variance may not be
182 granted unless the requesting medical marijuana treatment center
183 can demonstrate to the department that it has a proposed
184 alternative to the specific representation made in its
185 application which fulfills the same or a similar purpose as the
186 specific representation in a way that the department can
187 reasonably determine will not be a lower standard than the
188 specific representation in the application. A variance may not
189 be granted from the requirements in subparagraph 2. and
190 subparagraphs (b)1. and 2.
191 1. A licensed medical marijuana treatment center may
192 transfer ownership to an individual or entity who meets the
193 requirements of this section. A publicly traded corporation or
194 publicly traded company that meets the requirements of this
195 section is not precluded from ownership of a medical marijuana
196 treatment center. To accommodate a change in ownership:
197 a. The licensed medical marijuana treatment center shall
198 notify the department in writing at least 60 days before the
199 anticipated date of the change of ownership.
200 b. The individual or entity applying for initial licensure
201 due to a change of ownership must submit an application that
202 must be received by the department at least 60 days before the
203 date of change of ownership.
204 c. Upon receipt of an application for a license, the
205 department shall examine the application and, within 30 days
206 after receipt, notify the applicant in writing of any apparent
207 errors or omissions and request any additional information
209 d. Requested information omitted from an application for
210 licensure must be filed with the department within 21 days after
211 the department’s request for omitted information or the
212 application shall be deemed incomplete and shall be withdrawn
213 from further consideration and the fees shall be forfeited.
215 Within 30 days after the receipt of a complete application, the
216 department shall approve or deny the application.
217 2. A medical marijuana treatment center, and any individual
218 or entity who directly or indirectly owns, controls, or holds
219 with power to vote 5 percent or more of the voting shares of a
220 medical marijuana treatment center, may not acquire direct or
221 indirect ownership or control of any voting shares or other form
222 of ownership of any other medical marijuana treatment center.
223 3. A medical marijuana treatment center may not enter into
224 any form of profit-sharing arrangement with the property owner
225 or lessor of any of its facilities where cultivation,
226 processing, storing, or dispensing of marijuana and marijuana
227 delivery devices occurs.
228 4. All employees of a medical marijuana treatment center
229 must be 21 years of age or older and have passed a background
230 screening pursuant to subsection (9).
231 5. Each medical marijuana treatment center must adopt and
232 enforce policies and procedures to ensure employees and
233 volunteers receive training on the legal requirements to
234 dispense marijuana to qualified patients.
235 6. When growing marijuana, a medical marijuana treatment
237 a. May use pesticides determined by the department, after
238 consultation with the Department of Agriculture and Consumer
239 Services, to be safely applied to plants intended for human
240 consumption, but may not use pesticides designated as
241 restricted-use pesticides pursuant to s. 487.042.
242 b. Must grow marijuana within an enclosed structure and in
243 a room separate from any other plant.
244 c. Must inspect seeds and growing plants for plant pests
245 that endanger or threaten the horticultural and agricultural
246 interests of the state in accordance with chapter 581 and any
247 rules adopted thereunder.
248 d. Must perform fumigation or treatment of plants, or
249 remove and destroy infested or infected plants, in accordance
250 with chapter 581 and any rules adopted thereunder.
251 7. Each medical marijuana treatment center must produce and
252 make available for purchase at least one low-THC cannabis
254 8. A medical marijuana treatment center that produces
255 edibles must hold a permit to operate as a food establishment
256 pursuant to chapter 500, the Florida Food Safety Act, and must
257 comply with all the requirements for food establishments
258 pursuant to chapter 500 and any rules adopted thereunder.
259 Edibles may not contain more than 200 milligrams of
260 tetrahydrocannabinol, and a single serving portion of an edible
261 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles
262 may have a potency variance of no greater than 15 percent.
263 Edibles may not be attractive to children; be manufactured in
264 the shape of humans, cartoons, or animals; be manufactured in a
265 form that bears any reasonable resemblance to products available
266 for consumption as commercially available candy; or contain any
267 color additives. To discourage consumption of edibles by
268 children, the department shall determine by rule any shapes,
269 forms, and ingredients allowed and prohibited for edibles.
270 Medical marijuana treatment centers may not begin processing or
271 dispensing edibles until after the effective date of the rule.
272 The department shall also adopt sanitation rules providing the
273 standards and requirements for the storage, display, or
274 dispensing of edibles.
275 9. Within 12 months after licensure, a medical marijuana
276 treatment center must demonstrate to the department that all of
277 its processing facilities have passed a Food Safety Good
278 Manufacturing Practices, such as Global Food Safety Initiative
279 or equivalent, inspection by a nationally accredited certifying
280 body. A medical marijuana treatment center must immediately stop
281 processing at any facility which fails to pass this inspection
282 until it demonstrates to the department that such facility has
283 met this requirement.
284 10. When processing marijuana, a medical marijuana
285 treatment center must:
286 a. Process the marijuana within an enclosed structure and
287 in a room separate from other plants or products.
288 b. Comply with department rules when processing marijuana
289 with hydrocarbon solvents or other solvents or gases exhibiting
290 potential toxicity to humans. The department shall determine by
291 rule the requirements for medical marijuana treatment centers to
292 use such solvents or gases exhibiting potential toxicity to
294 c. Comply with federal and state laws and regulations and
295 department rules for solid and liquid wastes. The department
296 shall determine by rule procedures for the storage, handling,
297 transportation, management, and disposal of solid and liquid
298 waste generated during marijuana production and processing. The
299 Department of Environmental Protection shall assist the
300 department in developing such rules.
301 d. Test the processed marijuana using a medical marijuana
302 testing laboratory before it is dispensed. Results must be
303 verified and signed by two medical marijuana treatment center
304 employees. Before dispensing, the medical marijuana treatment
305 center must determine that the test results indicate that low
306 THC cannabis meets the definition of low-THC cannabis, the
307 concentration of tetrahydrocannabinol meets the potency
308 requirements of this section, the labeling of the concentration
309 of tetrahydrocannabinol and cannabidiol is accurate, and all
310 marijuana is safe for human consumption and free from
311 contaminants that are unsafe for human consumption. The
312 department shall determine by rule which contaminants must be
313 tested for and the maximum levels of each contaminant which are
314 safe for human consumption. The Department of Agriculture and
315 Consumer Services shall assist the department in developing the
316 testing requirements for contaminants that are unsafe for human
317 consumption in edibles. The department shall also determine by
318 rule the procedures for the treatment of marijuana that fails to
319 meet the testing requirements of this section, s. 381.988, or
320 department rule. The department may select a random sample from
321 edibles available for purchase in a dispensing facility which
322 shall be tested by the department to determine that the edible
323 meets the potency requirements of this section, is safe for
324 human consumption, and the labeling of the tetrahydrocannabinol
325 and cannabidiol concentration is accurate. A medical marijuana
326 treatment center may not require payment from the department for
327 the sample. A medical marijuana treatment center must recall
328 edibles, including all edibles made from the same batch of
329 marijuana, which fail to meet the potency requirements of this
330 section, which are unsafe for human consumption, or for which
331 the labeling of the tetrahydrocannabinol and cannabidiol
332 concentration is inaccurate. The medical marijuana treatment
333 center must retain records of all testing and samples of each
334 homogenous batch of marijuana for at least 9 months. The medical
335 marijuana treatment center must contract with a marijuana
336 testing laboratory to perform audits on the medical marijuana
337 treatment center’s standard operating procedures, testing
338 records, and samples and provide the results to the department
339 to confirm that the marijuana or low-THC cannabis meets the
340 requirements of this section and that the marijuana or low-THC
341 cannabis is safe for human consumption. A medical marijuana
342 treatment center shall reserve two processed samples from each
343 batch and retain such samples for at least 9 months for the
344 purpose of such audits. A medical marijuana treatment center may
345 use a laboratory that has not been certified by the department
346 under s. 381.988 until such time as at least one laboratory
347 holds the required certification, but in no event later than
348 July 1, 2018.
349 e. Package the marijuana in compliance with the United
350 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss.
351 1471 et seq.
352 f. Package the marijuana in a receptacle that has a firmly
353 affixed and legible label stating the following information:
354 (I) The marijuana or low-THC cannabis meets the
355 requirements of sub-subparagraph d.
356 (II) The name of the medical marijuana treatment center
357 from which the marijuana originates.
358 (III) The batch number and harvest number from which the
359 marijuana originates and the date dispensed.
360 (IV) The name of the physician who issued the physician
362 (V) The name of the patient.
363 (VI) The product name, if applicable, and dosage form,
364 including concentration of tetrahydrocannabinol and cannabidiol.
365 The product name may not contain wording commonly associated
366 with products marketed by or to children.
367 (VII) The recommended dose.
368 (VIII) A warning that it is illegal to transfer medical
369 marijuana to another person.
370 (IX) A marijuana universal symbol developed by the
372 11. The medical marijuana treatment center shall include in
373 each package a patient package insert with information on the
374 specific product dispensed related to:
375 a. Clinical pharmacology.
376 b. Indications and use.
377 c. Dosage and administration.
378 d. Dosage forms and strengths.
379 e. Contraindications.
380 f. Warnings and precautions.
381 g. Adverse reactions.
382 12. In addition to the packaging and labeling requirements
383 in subparagraphs 10. and 11., marijuana in a form for smoking
384 must be packaged in a sealed receptacle with a legible and
385 prominent warning to keep away from children and a warning that
386 states marijuana smoke contains carcinogens and may negatively
387 affect health. Such receptacles for marijuana in a form for
388 smoking must be plain, opaque, and white without depictions of
389 the product or images other than the medical marijuana treatment
390 center’s department-approved logo and the marijuana universal
392 13. 12. Each edible shall be individually sealed in plain,
393 opaque wrapping marked only with the marijuana universal symbol.
394 Where practical, each edible shall be marked with the marijuana
395 universal symbol. In addition to the packaging and labeling
396 requirements in subparagraphs 10., and 11., and 12., edible
397 receptacles must be plain, opaque, and white without depictions
398 of the product or images other than the medical marijuana
399 treatment center’s department-approved logo and the marijuana
400 universal symbol. The receptacle must also include a list all of
401 the edible’s ingredients, storage instructions, an expiration
402 date, a legible and prominent warning to keep away from children
403 and pets, and a warning that the edible has not been produced or
404 inspected pursuant to federal food safety laws.
405 14. 13. When dispensing marijuana or a marijuana delivery
406 device, a medical marijuana treatment center:
407 a. May dispense any active, valid order for low-THC
408 cannabis, medical cannabis and cannabis delivery devices issued
409 pursuant to former s. 381.986, Florida Statutes 2016, which was
410 entered into the medical marijuana use registry before July 1,
412 b. May not dispense more than a 70-day supply of marijuana
413 to a qualified patient or caregiver.
414 c. Must have the medical marijuana treatment center’s
415 employee who dispenses the marijuana or a marijuana delivery
416 device enter into the medical marijuana use registry his or her
417 name or unique employee identifier.
418 d. Must verify that the qualified patient and the
419 caregiver, if applicable, each have an active registration in
420 the medical marijuana use registry and an active and valid
421 medical marijuana use registry identification card, the amount
422 and type of marijuana dispensed matches the physician
423 certification in the medical marijuana use registry for that
424 qualified patient, and the physician certification has not
425 already been filled.
426 e. May not dispense marijuana to a qualified patient who is
427 younger than 18 years of age. If the qualified patient is
428 younger than 18 years of age, marijuana may only be dispensed to
429 the qualified patient’s caregiver.
430 f. May not dispense or sell any other type of cannabis,
431 alcohol, or illicit drug-related product , including pipes,
432 bongs, or wrapping papers, other than a marijuana delivery
433 device required for the medical use of marijuana and which is
434 specified in a physician certification.
435 g. Must, upon dispensing the marijuana or marijuana
436 delivery device, record in the registry the date, time,
437 quantity, and form of marijuana dispensed; the type of marijuana
438 delivery device dispensed; and the name and medical marijuana
439 use registry identification number of the qualified patient or
440 caregiver to whom the marijuana delivery device was dispensed.
441 h. Must ensure that patient records are not visible to
442 anyone other than the qualified patient, his or her caregiver,
443 and authorized medical marijuana treatment center employees.
444 (14) EXCEPTIONS TO OTHER LAWS.—
445 (a) Notwithstanding s. 893.13, s. 893.135, s. 893.147, or
446 any other provision of law, but subject to the requirements of
447 this section, a qualified patient and the qualified patient’s
448 caregiver may purchase from a medical marijuana treatment center
449 for the patient’s medical use a marijuana delivery device and up
450 to the amount of marijuana authorized in the physician
451 certification, but may not possess more than a 70-day supply of
452 marijuana at any given time and all marijuana purchased must
453 remain in its original packaging.
454 (b) Notwithstanding paragraph (a), s. 893.13, s. 893.135,
455 s. 893.147, or any other provision of law, a qualified patient
456 and the qualified patient’s caregiver may purchase and possess a
457 marijuana delivery device intended for the medical use of
458 marijuana by smoking from a vendor other than a medical
459 marijuana treatment center if such delivery device, or a similar
460 delivery device, is specified in that patient’s certification
461 issued by a qualified physician.
462 (c) (b) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
463 or any other provision of law, but subject to the requirements
464 of this section, an approved medical marijuana treatment center
465 and its owners, managers, and employees may manufacture,
466 possess, sell, deliver, distribute, dispense, and lawfully
467 dispose of marijuana or a marijuana delivery device as provided
468 in this section, s. 381.988, and by department rule. For the
469 purposes of this subsection, the terms “manufacture,”
470 “possession,” “deliver,” “distribute,” and “dispense” have the
471 same meanings as provided in s. 893.02.
472 (d) (c) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
473 or any other provision of law, but subject to the requirements
474 of this section, a certified marijuana testing laboratory,
475 including an employee of a certified marijuana testing
476 laboratory acting within the scope of his or her employment, may
477 acquire, possess, test, transport, and lawfully dispose of
478 marijuana as provided in this section, in s. 381.988, and by
479 department rule.
480 (e) (d) A licensed medical marijuana treatment center and
481 its owners, managers, and employees are not subject to licensure
482 or regulation under chapter 465 or chapter 499 for
483 manufacturing, possessing, selling, delivering, distributing,
484 dispensing, or lawfully disposing of marijuana or a marijuana
485 delivery device, as provided in this section, in s. 381.988, and
486 by department rule.
487 (f) (e) This subsection does not exempt a person from
488 prosecution for a criminal offense related to impairment or
489 intoxication resulting from the medical use of marijuana or
490 relieve a person from any requirement under law to submit to a
491 breath, blood, urine, or other test to detect the presence of a
492 controlled substance.
493 (g) (f) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
494 or any other provision of law, but subject to the requirements
495 of this section and pursuant to policies and procedures
496 established pursuant to s. 1006.62(8), school personnel may
497 possess marijuana that is obtained for medical use pursuant to
498 this section by a student who is a qualified patient.
499 (h) (g) Notwithstanding s. 893.13, s. 893.135, s. 893.147,
500 or any other provision of law, but subject to the requirements
501 of this section, a research institute established by a public
502 postsecondary educational institution, such as the H. Lee
503 Moffitt Cancer Center and Research Institute, Inc., established
504 under s. 1004.43, or a state university that has achieved the
505 preeminent state research university designation under s.
506 1001.7065 may possess, test, transport, and lawfully dispose of
507 marijuana for research purposes as provided by this section.
508 (15) APPLICABILITY.—
509 (a) This section does not limit the ability of an employer
510 to establish, continue, or enforce a drug-free workplace program
511 or policy.
512 (b) This section does not require an employer to
513 accommodate the medical use of marijuana in any workplace or any
514 employee working while under the influence of marijuana.
515 (c) This section does not create a cause of action against
516 an employer for wrongful discharge or discrimination.
517 (d) This section does not impair the ability of any party
518 to restrict or limit smoking on his or her private property.
519 (e) This section does not prohibit the medical use of
520 marijuana, or a caregiver assisting with the medical use of
521 marijuana, in a nursing home, licensed under part II of chapter
522 400; in a hospice facility, licensed under part IV of chapter
523 400; or in an assisted living facility, licensed under part I of
524 chapter 429, if the medical use of marijuana is not prohibited
525 in the facility’s policies.
526 (f) Marijuana, as defined in this section, is not
527 reimbursable under chapter 440.
528 Section 2. The proviso following Specific Appropriation 422
529 in section 3 of chapter 2018-9, Laws of Florida, and the proviso
530 following Specific Appropriation 424 in section 3 of chapter
531 2018-9, Laws of Florida, are repealed and the funds appropriated
532 by those specific appropriations which were affected by those
533 provisos are released from reserve.
534 Section 3. This act shall take effect upon becoming a law.